Robotic-assisted CABG reduces healthcare costs, primarily thanks to shorter hospital stays

Dokollari et al. provided a quick explanation of how these robotic-assisted surgeries worked.

“In short, robotic-assisted CABG includes the robotic harvest of the left internal thoracic artery (LITA) followed by its direct anastomosis to the left anterior descending artery with a small anterior thoracotomy (4 cm) at the site of the camera port,” they explained. “The robotic procedures start with the introduction of three ports in the midclavicular/anterior axillary line, in second, fourth and sixth intercostal space. The 3D view offered by the robotic platform enhances the visualization of the LITA, lowering the risk of vessel injury and enabling the surgeon to harvest a longer LITA graft by means of skeletonization. By extending the camera port size to a 4-cm skin incision, the surgeon can perform an off-pump coronary anastomosis using a composite off-pump retractor and off-pump technique to complete the anastomosis.”

Beginning with clinical outcomes, the authors reported that traditional CABG patients were associated with spending twice as much time in the ICU and spending two more full days at the hospital than robotic-assisted CABG patients. Traditional CABG patients were also linked to higher rates of blood product transfusions and new-onset atrial fibrillation (AFib).

On the other hand, all-cause hospital readmissions in the first 30 days following treatment were nearly three times as common among robotic-assisted CABG patients (9%) than traditional CABG patients (3.4%).

Patients were followed for a median follow-up period of 1.5 years. Rates of all-cause mortality, stroke, myocardial infarction and repeat intervention were all comparable between the two treatment techniques.

Moving on to the costs of each technique, Dokollari and colleagues found that the total costs linked to robotic-assisted CABG were approximately $5 million, or $18,726 per patient, and the total costs linked to traditional CABG were approximately $9.5 million, or $35,580 per patient.

Even when adding in the total cost of the robotic surgical system—approximately $1.2 million—the indirect and direct costs were significantly lower among patients treated with robotic-assisted CABG.

Length of stay, the researchers noted, appeared to make the most significant impact on total costs by far. This highlights the importance of tracking post-operative outcomes such as new-onset AFib, which can cause patients to spend a longer time in the hospital.

The team also emphasized that it may take time for surgeons to feel comfortable using these robotic surgical systems.

“A surgeon on the early learning curve of the procedure is likely to incur higher initial operative costs than one who has performed 50-100 cases,” they wrote.  

Click here for the full study.